ClinicalTrials.Veeva

Menu

Fluorescence-navigated Thoracoscopy for Pulmonary Segmentectomy

P

Peking University

Status

Unknown

Conditions

Pulmonary Segmentectomy

Treatments

Procedure: Indocyanine Green Injection through Peripheral Vein

Study type

Interventional

Funder types

Other

Identifiers

NCT04160884
2018PHB143-01

Details and patient eligibility

About

Recently developed fluorescence-navigated thoracoscopy with indocyanine green (ICG) is being used for various kinds of pulmonary surgery, and several studies have reported the application of this novel technique in demarcation of the intersegmental border for segmentectomy. This study is performed prospectively to find out, for the first time, the optimal dosage of ICG in human body to ensure safe and sustained imaging during segmentectomy.

Enrollment

68 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suitable for segmentectomy and signed informed consent

Exclusion criteria

  • Liver dysfunction.
  • Allergic to indocyanine green.
  • Can't tolerate thoracoscopic surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

68 participants in 2 patient groups

A
Active Comparator group
Description:
0.6mg/kg of ICG, iv
Treatment:
Procedure: Indocyanine Green Injection through Peripheral Vein
B
Experimental group
Description:
0.2mg/kg of ICG, iv
Treatment:
Procedure: Indocyanine Green Injection through Peripheral Vein

Trial contacts and locations

1

Loading...

Central trial contact

Feng Yang, MD; Tiezheng Li, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems